Vorinostat: A New Oral Histone Deacetylase Inhibitor Approved for Cutaneous T-Cell Lymphoma, Expert Opin. Investig. Drugs, vol.16, 1111. ,
, Belinostat: First Global Approval. Drugs, vol.74, pp.1543-1554, 2014.
Approves New Agent for Multiple Myeloma, J. Natl. Cancer Inst, p.165, 2015. ,
Romidepsin: A New Therapy for Cutaneous T-Cell Lymphoma and a Potential Therapy for Solid Tumors, Expert Rev. Anticancer Ther, vol.10, pp.997-1008, 2010. ,
, Chidamide in Relapsed or Refractory Peripheral T Cell Lymphoma: A Multicenter Real-World Study in China. J. Hematol. Oncol.J. Hematol Oncol, vol.10, p.69, 2017.
The Future of Epigenetic Therapy in Solid Tumours: Lessons from the Past, Nat. Rev. Clin. Oncol, vol.10, pp.256-266, 2013. ,
Epigenetic Protein Families: A New Frontier for Drug Discovery, Nat. Rev. Drug Discovery, vol.11, pp.384-400, 2012. ,
Targeting of Histone Deacetylases to Reactivate Tumour Suppressor Genes and Its Therapeutic Potential in a Human Cervical Cancer Xenograft Model, PLoS One, vol.8, issue.e80657, 2013. ,
Histone Deacetylase 2 Controls P53 and Is a Critical Factor in Tumorigenesis, Biochim. Biophys. Acta, Rev. Cancer, pp.524-538, 1846. ,
Histone Deacetylase 3 Inhibits New Tumor Suppressor Gene DTWD1 in Gastric Cancer, Am. J. Cancer Res, vol.5, pp.663-673, 2015. ,
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents, Molecules, vol.20, p.3898, 2015. ,
Inside HDACs with More Selective HDAC Inhibitors, Eur. J. Med. Chem, vol.121, pp.451-483, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01505640
Histone Deacetylase Inhibitors: Emerging Mechanisms of Resistance, Mol. Pharmaceutics, 2011. ,
Deprez-Poulain, R. Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox, J. Med. Chem, vol.60, pp.9067-9089, 2017. ,
What Are the Cancer Relevant Targets?, Cancer Lett, pp.277-285, 2009. ,
Exploration of the HDAC2 Foot Pocket: Synthesis and {SAR} of Substituted N-(2-Aminophenyl)Benzamides, Bioorg. Med. Chem. Lett, pp.3142-3145, 2010. ,
Structural Origin of Selectivity in Class II-Selective Histone Deacetylase Inhibitors, J. Med. Chem, vol.51, 2008. ,
Cross Metathesis with Hydroxamate and Benzamide BOC-Protected Alkenes to Access {HDAC} Inhibitors and Their Biological Evaluation Highlighted Intrinsic Activity of BOC-Protected Dihydroxamates, Bioorg. Med. Chem. Lett, vol.26, pp.154-159, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01299475
Inside HDAC with HDAC Inhibitors, Eur. J. Med. Chem, p.45, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01505640
1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells, J. Med. Chem, vol.57, pp.6259-6265, 2014. ,
Optimization of the in Vitro Cardiac Safety of Hydroxamate-Based Histone Deacetylase Inhibitors, J. Med. Chem, vol.54, pp.4752-4772, 2011. ,
Discovery of Histone Deacetylase 8 Selective Inhibitors, Bioorg. Med. Chem. Lett, 2011. ,
Pharmacological Characterization of Histone Deacetylase Inhibitor and Tumor Cell-Growth Inhibition Properties of New Benzofuranone Compounds, Curr. Cancer Drug Targets, vol.11, pp.919-928, 2011. ,
Design of PH Responsive Clickable Prodrugs Applied to Histone Deacetylase Inhibitors: A New Strategy for Anticancer Therapy, Eur. J. Pharm. Biopharm, vol.85, pp.862-72, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01006764
WNT7a Induces E-Cadherin in Lung Cancer Cells, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.10429-10434, 2003. ,
Semaphorins and Their Receptors in Lung Cancer, Cancer Lett, vol.273, pp.1-14, 2009. ,
P21 in Cancer: Intricate Networks and Multiple Activities, Nat. Rev. Cancer, vol.9, pp.400-414, 2009. ,
HDAC6 Is a Microtubule-Associated Deacetylase, Nature, vol.417, pp.455-458, 2002. ,
Efficacy of MS-275, a Selective Inhibitor of Class I Histone Deacetylases, in Human Colon Cancer Models, Int. J. Oncol, vol.35, pp.909-920, 2009. ,
Histone Deacetylase 6 Structure and Molecular Basis of Catalysis and Inhibition, Nat. Chem. Biol, vol.12, pp.741-747, 2016. ,
Computational Design of a Time-Dependent Histone Deacetylase 2 Selective Inhibitor, ACS Chem. Biol, vol.10, pp.687-692, 2015. ,
Structural Insights into HDAC6 Tubulin Deacetylation and Its Selective Inhibition, Nat. Chem. Biol, vol.12, pp.748-754, 2016. ,
Phenylalanine-Containing Hydroxamic Acids as Selective Inhibitors of Class IIb Histone Deacetylases (HDACs), Bioorg. Med. Chem, vol.16, 2008. ,